A brief introductory video explaining Micropore's unique membrane-based system

Watch a video about our unique technology

Our Unique Technology

Contact Us


  • Single Device

    The AXF Mini. One device for discovery, preclinical & clinical stages. Start at 1-2mL. Turn it up to 10-20mL. And finally up-scale to 100’s mL.

  • Scale-up Made Simple

    From inception to manufacturing. Consistent mechanism, conditions & geometry.

  • Robust & Simple to Operate

    Technology that just works. No moving parts. No single-use plastic. No hassle.

  • Global Service

    Rapid delivery. Unrivalled formulation expertise. Support throughout your journey.

Advanced Crossflow. For your product development journey from inception to final delivery


Micropore’s range of advanced crossflow equipment is a unique system that utilises consistent physics, mechanism, conditions and geometry across a range of devices enabling development using a micro device with 100,000 pores delivering as little as 1ml which can be simply accelerated to deliver 20 litres of formulation per hour. And the micro device configuration is seamless transferable to industrial scale units with 10 million pores capable of outputting outputs of 1500 litres per hour."

From the low shear micro mixing required for the production of mRNA loaded lipid nano particles; to dispersed biodegradable PLGA particles with a narrower size distribution; and amorphous crystallisation of APIs for improved bioavailability, Micropore’s patented crossflow membrane technology is revolutionising the world of product formulation.

Micropore Particle Engineering

In pharmaceuticals and biopharmaceuticals, we do much more than the demanding micro- and nanoparticle injectables. Micropore has over 100 years of accumulated expertise in the formulation of different drug product delivery systems.

We can help you engineer your ideal delivery formulation whatever the method you choose:

  • Microspheres
  • Microcapsules
  • Emulsions
  • Crystallisation

Got a Challenge?

At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.

Ask an expert

Server Render

Latest from Micropore

LNP Formulation & Process Development Summit in Boston

29th April 2022

During April Micropore was delighted to contribute to the global pharmaceutical industry’s first forum dedicated to bringing together drug developers within the LNP field, organised by Hanson Wade at the Boston Park Plaza Hotel. Micropore's CEO joined an eminent team of scientist to discuss the issues surrounding this pioneering new therapeutic technique and presented a paper on the scale up advantages of formulating using advanced crossflow technology.

Follow Us

Unable to load video. Please check that provider and source id have been supplied.

Stay Informed

Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.

Download the latest edition of the Micropore newsletter

Alternatively, you can download the latest edition of the Micropore newsletter HERE.